This is not the latest version of this item. The latest version can be found here.
A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density
Name
1-s2.0-S1550413121000012-main.pdf
Description
Published version
Size
3.21 MB
Format
Adobe PDF
Checksum (MD5)
0ad5e77238af7df8fd535aaa80e0e4b6
Author(s) • • • • • • • • •
Sinnott-Armstrong, N
Sousa, IS
Laber, S
Rendina-Ruedy, E
Nitter Dankel, SE
Ferreira, T
Mellgren, G
Karasik, D
Rivas, M
Pritchard, J
Date Issued
March 2, 2021
Journal
Cell Metabolism
Publisher
Elsevier BV
Version
Final published version
Abstract
Nasa Sinnott-Armstrong and colleagues identify a pleiotropic risk locus at 3q21 that is associated with type 2 diabetes (T2D) and greater bone mineral density (BMD) and its associated cell-autonomous mechanisms in adipocytes and osteoblasts. Together, these findings provide a possible explanation for the perplexing finding that individuals with T2D have higher BMD but greater susceptibility to bone fracture.
Terms of Use
Creative Commons Attribution 4.0 International license
Persistent DSpace Link
DOI of Published Version
10.1016/j.cmet.2021.01.001